Showing results (241-250 of 301) with videos related to
Sort By:
Pageof 31
Biomedicines|December 2, 2020
Targeting Stereotactic Body Radiotherapy on Metabolic PET- and Immuno-PET-Positive Vertebral MetastasesBaptiste Pichon, Caroline Rousseau, Audrey Blanc-Lapierre, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)ReFrank G van Schaijk, Egbert Oosterwijk, Annemiele C Soede, et al.European Journal of Haematology|August 10, 2013
BCR-ABL1 molecular remission after 90Y-epratuzumab tetraxetan radioimmunotherapy in CD22+ Ph+ B-ALL: proof of principlePatrice Chevallier, Caroline Bodet-Milin, Nelly Robillard, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 26, 2011
Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibodyCatharina M van Rij, Robert M Sharkey, David M Goldenberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Pretargeting of carcinoembryonic antigen-expressing cancers with a trivalent bispecific fusion protein produced in myeloma cellsEdmund A Rossi, Chien-Hsing Chang, Michele J Losman, et al.EJNMMI Research|January 31, 2012
Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection methodRafke Schoffelen, Winette Ta van der Graaf, Robert M Sharkey, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 8, 2005
Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC modelsFrank G van Schaijk, Egbert Oosterwijk, Janneke D Molkenboer-Kuenen, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 16, 2013
Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibodyCatharina M van Rij, Susanne Lütje, Cathelijne Frielink, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptideWilliam J McBride, Pat Zanzonico, Robert M Sharkey, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trialFrançoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, et al.Pageof 31